MS
Satellos Bioscience Inc. Common Stock (MSLE)
NASDAQ·Healthcare·Medical - Pharmaceuticals
$9.44
-0.21%
Mkt Cap $15.01M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$23.00
Range $23.00 – $23.00
Implied Upside
+143.6%
Consensus $23.00 vs current $9.44